PHARMAKES
ActiveSummary
PHARMAKES has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €32,749. Equity is growing by about 23% per year across the filed financial years. Its solvency ranks better than 80% of 12,650 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2025
31-10
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
18-04
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 13-03-2025
- Registered-office move, Izegrimstraat 4, 8900 Ieper
31-03
Financial
Weakest financial yearnet €32,749 ▼70.2%
Net result drops to €32,749, the lowest in the series.
31-03
Financial
Liquidity more than triplescurrent ratio 12.17
Current ratio from 3.56 to 12.17; short-term debt falls from €338,362 to €79,578.
2024
30-10
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2023
01-12
Gazette deed
Appointment: Roel KESTELYN (director)Capital conversion · Purpose change · Amendment of the articles14 facts ▸
Gazette deed
Appointment: Roel KESTELYN (director)
Capital conversion · Purpose change · Amendment of the articles14 facts ▸
- Other provision, “vervangen ambtgenoot-notaris, wettelijk belet” (deed in Dutch) (3 times)
- General meeting, 23-11-2023
- Capital conversion, “onmiddellijke en integrale opheffing onbeschikbaarheid statutair onbeschikbare eigenvermogensrekening, mits inachtneming alsdan geldende wettelijke en/of statut…” (deed in Dutch)
- Purpose change (2 times)
- Amendment of the articles (2 times)
- Other provision, “bevestiging benoeming enige thans in functie zijnde(niet-statutaire)bestuurder” (deed in Dutch)
- Other provision, “vaststelling huidig adres zetel vennootschap,website en e-mailadres” (deed in Dutch)
- Other provision, “machten agendapunt 6” (deed in Dutch)
- Capital conversion, “onmiddellijke en integrale opheffing onbeschikbaarheid statutair onbeschikbare eigenvermogensrekening, EERSTE BESLUIT” (deed in Dutch)
- Capital
- Director appointment, Roel KESTELYN (director)
- Registered office clause, “8900 Ieper,Capucienenstraat 56, Vlaams Gewest” (deed in Dutch)
- +2 further facts in this act
27-10
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
31-03
Financial
Highest result from 2019 to 2025net €283,001 ▲39.4%
Operating result €423,004, net result €283,001, both a record.
31-03
Financial
Equity above €1mequity €1.0m ▲37%
A profit in every financial year since 2019 builds equity to €1.0m.
2022
10-11
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 10 days late
2021
03-11
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 3 days late
31-03
Financial
Equity above €500,000equity €561,351 ▲55.7%
A profit in every financial year since 2019 builds equity to €561,351.
Show earlier events
2020
17-11
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 17 days late
31-03
Financial
Liquidity more than doubledcurrent ratio 4.87
Current ratio from 1.80 to 4.87; short-term debt falls from €279,031 to €82,822.
2019
08-11
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 8 days late
2018
28-09
NBB filing
Annual accounts filed
financial year 2018 · micro format
2017
12-10
NBB filing
Annual accounts filed
financial year 2017 · micro format
2016
27-09
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
2 of 5 deeds read
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.